Wright Medical slides in Q1; Navidea launches Lymphoseek in the U.S.;

@FierceMedDev: Natera hauls in $54.6M for prenatal Dx. News | Follow @FierceMedDev

@MarkHFierce: An MRI scan to measure brain atrophy could predict MS, a new University at Buffalo study has determined. More | Follow @MarkHFierce

 @DamianFierce: Join us for a trip through why a repeal of the medical device tax is unlikely to happen any time soon. Editor's corner | Follow @DamianFierce

> Sales at Wright Medical ($WMGI) declined in its fiscal 2013 first quarter, impacted in part by price decreases in Japan but offset to a degree by a growing global foot and ankle business. Release

> Navidea Biopharmaceuticals ($NAVB) has launched its diagnostic aid Lymphoseek in the U.S. More

> Medical device entrepreneurs say that FDA policies are killing innovation. Story

> GI Dynamics ($GID) appointed Amylin Pharmaceuticals veteran David Maggs as its new chief medical officer. News

> Cleveland Clinic spinout Rindex Medical is developing a tool that would help predict which patients will face atrial fibrillation after cardiac surgery, which would flag them for preemptive treatment to prevent problems. Story

> Haemonetics ($HAE) raked in $249.9 million in revenue last quarter, a 34% increase, but net income dropped 29% to $12.6 million. Results

> Breast implants can delay doctors' ability to diagnose breast cancer, according to a study. Article

> Sanuwave Health has named Pfizer ($PFE) veteran Daniel Jorgensen as its new CMO. Item

Biotech News

@FierceBiotech: ICYMI, check out newest Industry Voices: Time to Take Fecal Transplantation Seriously. Feature | Follow @FierceBiotech

@JohnCFierce: Seems likely to me that Merck is going to cut open R&D and do some major surgery. Perlmutter is two weeks on the job. | Follow @JohnCFierce

@RyanMFierce: Just talked to Semantelli about IMS Health deal: IMS Health acquires social media analytics startup Semantelli. Report | Follow @RyanMFierce

> Merck spotlights new deals, R&D review as demands to rebuild pipeline grow. Story

> VCs provide $40M to finance Celator's pivotal PhIII AML study. News

> FDA steamrolls over panel vote, spurns Titan's addiction drug Probuphine. Article

Pharma News

@FiercePharma: Scary-odd news from Bloomberg: Amgen blood drugs may help victims survive nuclear attack. Story | Follow @FiercePharma

@EricPFierce: FDA tests the waters on Plan B, approves it for girls 15 and older, off the shelf but requires proof of age. Report | Follow @EricPFierce

> Novo's exceptional first quarter still disappoints. Report

> Amgen blood drugs may help humans survive nuclear attack, FDA says. Article

> Lagging Januvia weighs on Merck's none-too-pretty first quarter. More

Biomarkers News

> Dozens of new biomarkers gauge ovarian cancer survival prospects. Report

> Investigators profile a lethal tumor cell that could spur metastasis. Article

> Verastem gears up for companion Dx mesothelioma treatment trial. More

> Brain atrophy could predict MS, study finds. Story

> Key biomarker measure + CT scan predict melanoma survival odds. Item

Drug Delivery News

@MichaelGFierce: Merck, Celgene cancer nanomeds combined for better delivery. Report | Follow @MichaelGFierce

> Researchers open window through blood-brain barrier. Story

> ClearPoint MRI-guided device sheds light on drug delivery to the brain. Editor's corner

> 'Spider' protein can deliver stable vaccines in high concentration. More

> Insuline's InsuPatch delivery device suffers FDA setback. Item

 

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.